All Pharma articles – Page 40
-
Information36 Richard Barker
Director general of the Association of British Pharmaceutical Industries, Richard Barker has been at the heart of many wrangles over drug costs and availability.
-
Information50 Ben Goldacre
An honourable 50th position for the NHS’s own myth buster - The Guardian columnist and author of Bad Science Dr Ben Goldacre.
-
NewsMicrosoft on the lookout for NHS business
Microsoft is “investigating opportunities” for introducing its personal health record platform in the NHS in England.
-
CommentMedia Watch: drugs debate
The sacking of senior government adviser David Nutt has resulted in the biggest media debate on illegal drugs for many months.
-
NewsDrug firm to compensate NHS
Scotland’s health secretary Nicola Sturgeon has welcomed a settlement being reached with a pharmaceutical company over alleged anti-competitive behaviour in the supply of drugs to the NHS.
-
NewsPCTs defend closer working with NICE
Primary care trusts and the National Institute for Health and Clinical Excellence have defended a £300,000 a year contract designed to help PCTs influence NICE appraisals.
-
HSJ Knowledge
Joint working with the pharmaceutical industry
Steve Williamson, Sean McGrath and Abbie Pound explore the importance of collaborative working between healthcare providers and the pharmaceutical industry - facilitated by medical education agencies - and what this might mean for patient care
-
InformationIan Dalton's swine flu update - vaccine distribution plans
In his weekly update for HSJ and Nursing Times, national director for NHS flu resilience Ian Dalton discusses the latest developments in UK swine flu preparations
-
NewsMedication errors 'affect 70pc of care home residents'
Overworked care home staff, poor teamwork and lack of training mean seven in 10 elderly residents are subject to medication errors.
-
NewsScottish prescription costs soar to £1.07bn
Prescriptions are now costing the NHS in Scotland £1.07bn a year, latest figures show.
-
NewsPressure to follow NICE guidelines 'will increase'
The public spending squeeze means primary care trusts are likely to come under greater scrutiny over their following of recommendations in National Institute for Health and Clinical Excellence guidelines and technology appraisals.
-
NewsHospital changes prescription practices after chemotherapy overdose
A Bristol hospital has announced a range of “robust” changes to its prescription practices after a consultant killed a patient by accidentally administering a chemotherapy dose four times higher than the recommended limit.
-
NewsNICE approves stomach tumour treatment
Sunitinib has been recommended by NICE for gastro-intestinal stromal tumours after a pricing deal with maker Pfizer.
-
NewsSwine flu vaccination programme extended to pharmacists
Frontline pharmacists and their staff must be included in the priority swine flu vaccination programme, NHS flu resilience director Ian Dalton has said.
-
NewsNHS drug errors 'may top 860,000'
The number of mistakes involving NHS patients being given the wrong medication may total 860,850, according to the National Patient Safety Agency.
-
HSJ KnowledgeGeneric medications warning from NHS Confederation
Government plans to have branded versions of drugs routinely swapped for generic equivalents must not be allowed to compromise patient safety, the NHS Confederation has warned.
-
NewsNHS trusts slammed by DH over 'unacceptable' plans to export drugs
NHS hospital trusts have been slammed by the Department of Health over “wholly unacceptable” plans to cash in on the weak pound by exporting medicines intended for NHS patients.
-
NewsSwine flu cases on the decrease
The number of people newly diagnosed with swine flu in England continues to fall, with an estimated 5,000 cases last week, figures reveal.
-
NewsPost-Shipman drug regulations working, says CQC
Measures brought in to prevent a repeat of the case of homicidal doctor Harold Shipman have been successful, the Care Quality Commission has said.
-
NewsSwine flu antiviral guidance issued
Otherwise healthy people who contract the H1N1 “swine flu” virus do not need to be treated with antivirals if their symptoms are uncomplicated, the World Health Organisation has said.